Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients

Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...

Полное описание

Библиографические подробности
Главные авторы:	Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K
Формат:	Journal article
Опубликовано:	American Society for Clinical Investigation 2019

Схожие документы

Diagnostic use of autoantibodies in myasthenia gravis.
по: Leite, M, и др.
Опубликовано: (2010)

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
по: Miriam L. Fichtner, и др.
Опубликовано: (2022-10-01)

Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
по: Gomez, A, и др.
Опубликовано: (2016)

Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
по: Miriam L Fichtner, и др.
Опубликовано: (2022-01-01)

Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
по: Miriam L. Fichtner, и др.
Опубликовано: (2022-01-01)

Collagen Q - A potential target for autoantibodies in myasthenia gravis.
по: Zoltowska Katarzyna, M, и др.
Опубликовано: (2015)

The search for new antigenic targets in myasthenia gravis.
по: Cossins, J, и др.
Опубликовано: (2012)

Autoantibodies to agrin in myasthenia gravis patients.
по: Bin Zhang, и др.
Опубликовано: (2014-01-01)

Autoantibodies against neurologic antigens in nonneurologic autoimmunity
по: Stathopoulos, P, и др.
Опубликовано: (2019)

Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
по: Vincent, A, и др.
Опубликовано: (2012)

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
по: Saxena, A, и др.
Опубликовано: (2017)

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
по: Mygland, A, и др.
Опубликовано: (2000)

Autoantibodies in myasthenia gravis: cluster analysis and clinical correlations
по: Xupeng Sun, и др.
Опубликовано: (2025-02-01)

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
по: Inga Koneczny, и др.
Опубликовано: (2019-07-01)

Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis
по: Shigeo Iijima
Опубликовано: (2021-11-01)

Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
по: Miriam L. Fichtner, и др.
Опубликовано: (2020-05-01)

Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
по: Martínez-Martínez, P, и др.
Опубликовано: (2007)

PATHOGENIC MECHANISMS UNDERLYING MYASTHENIA GRAVIS ASSOCIATED WITH MUSK ANTIBODIES
по: Viegas, S, и др.
Опубликовано: (2009)

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
по: Damato, V, и др.
Опубликовано: (2022)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
по: Park, K, и др.
Опубликовано: (2018)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
по: Phillips, W, и др.
Опубликовано: (2015)

Antibodies in myasthenia gravis and related disorders.
по: Vincent, A, и др.
Опубликовано: (2003)

Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
по: Vincent, A
Опубликовано: (2008)

Detection and clinical significance of serum autoantibodies in patients with myasthenia gravis
по: Yun LIU, и др.
Опубликовано: (2016-10-01)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
по: Konstantinos Lazaridis, и др.
Опубликовано: (2020-02-01)

Myasthenia gravis.
по: Vincent, A, и др.
Опубликовано: (2004)

A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
по: Koneczny, I, и др.
Опубликовано: (2024)

Myasthenia gravis: diagnostic and management dilemmas.
по: Palace, J, и др.
Опубликовано: (2001)

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
по: Losen, M, и др.
Опубликовано: (2005)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
по: Lee, J, и др.
Опубликовано: (2016)

Myasthenia gravis
по: Massey Janice M, и др.
Опубликовано: (2007-11-01)

Antibodies to AChRs in seronegative myasthenia gravis
по: Leite, M, и др.
Опубликовано: (2006)

Scenarios for autoimmunization of T and B cells in myasthenia gravis.
по: Shiono, H, и др.
Опубликовано: (2003)

Myasthenia Gravis and Pregnancy
по: Papish M., и др.
Опубликовано: (2018-12-01)

SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS
по: Huda, S, и др.
Опубликовано: (2014)

Thymoma and paraneoplastic myasthenia gravis.
по: Marx, A, и др.
Опубликовано: (2010)

Neuromyotonia in thymoma-associated myasthenia gravis: a clinico-serological study
по: Gastaldi, M, и др.
Опубликовано: (2018)

Serological and experimental studies in different forms of myasthenia gravis
по: Vincent, A, и др.
Опубликовано: (2018)

Seronegative myasthenia gravis.
по: Vincent, A, и др.
Опубликовано: (2004)

Myasthenia gravis.
по: Vincent, A, и др.
Опубликовано: (2001)